Entera Bio Ltd (NAS:ENTX) Stock News, Headlines & Updates
Entera Bio Ltd Stock News from GuruFocus
- 1
Jul 08, 2025
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
Marketwired • 7:00am
Jun 26, 2025
Entera Bio (ENTX) Highlights Dual Action of EB613 at ASBMR 2025 | ENTX Stock News
GuruFocus News • 7:47am
Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting | ENTX Stock News
GuruFocus News • 7:21am
Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting
Marketwired • 7:00am
Jun 25, 2025
ENTX: Entera Bio and OPKO Health's Collaboration on Innovative Treatment | ENTX Stock News
GuruFocus News • 7:31am
Entera Bio (ENTX) Announces Data Presentation at ENDO 2025 | ENTX Stock News
GuruFocus News • 7:31am
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
GuruFocus News • 7:23am
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
Marketwired • 7:00am
May 30, 2025
Entera Bio (ENTX) Registers $100 Million Mixed Securities Shelf Offering | ENTX Stock News
GuruFocus News • 3:45pm
May 09, 2025
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
Marketwired • 4:00pm
Entera Bio Ltd (ENTX) Q1 2025 Earnings: EPS of -$0.06 Beats Estimate, Reports Net Loss of $2.6 Million
GuruFocus News • 3:32pm
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates | ENTX Stock News
GuruFocus News • 3:18pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news